Global Live Cell Encapsulation Market 2021 by Company, Regions, Type and Application, Forecast to 2026

Global Live Cell Encapsulation Market 2021 by Company, Regions, Type and Application, Forecast to 2026

Page: 91

Published Date: 09 Jul 2021

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

  • sp_icon1 sp_icon1_b Description
  • sp_icon2 sp_icon2_b Table of Contents
  • sp_icon3 sp_icon3_b Table of Figures
  • sp_icon4 sp_icon4_b Research Methodology
  • sp_icon1 sp_icon1_b Companies Mentioned
  • sp_icon1 sp_icon1_b Related Reports
  • sp_icon1 sp_icon1_b Product Tags
btl

Description

The Live Cell Encapsulation market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Live Cell Encapsulation size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global Live Cell Encapsulation market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation
Live Cell Encapsulation market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
Alginate
Chitosan
Cellulose
Others

Market segment by Application, can be divided into
Diabetes
Cancer
Epilepsy
Parkinson
Others

Market segment by players, this report covers
Viacyte, Inc.
Living Cell Technologies Ltd.
Sigilon Therapeutics, Inc
Sernova Corporation
PharmaCyte Biotech Inc
Gloriana Therapeutics
Kadimastem
Beta-O2 Technologies, Inc.
Altucell, Inc.
Diatranz Otsuka Ltd

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Live Cell Encapsulation product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Live Cell Encapsulation, with revenue, gross margin and global market share of Live Cell Encapsulation from 2019 to 2021.
Chapter 3, the Live Cell Encapsulation competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by type and application, with revenue and growth rate by type, application, from 2016 to 2026.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2016 to 2021.and Live Cell Encapsulation market forecast, by regions, type and application, with revenue, from 2021 to 2026.
Chapter 11 and 12, to describe Live Cell Encapsulation research findings and conclusion, appendix and data source.
btl

Table of Contents

1 Market Overview
1.1 Product Overview and Scope of Live Cell Encapsulation
1.2 Classification of Live Cell Encapsulation by Type
1.2.1 Overview: Global Live Cell Encapsulation Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Live Cell Encapsulation Revenue Market Share by Type in 2020
1.2.3 Alginate
1.2.4 Chitosan
1.2.5 Cellulose
1.2.6 Others
1.3 Global Live Cell Encapsulation Market by Application
1.3.1 Overview: Global Live Cell Encapsulation Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Diabetes
1.3.3 Cancer
1.3.4 Epilepsy
1.3.5 Parkinson
1.3.6 Others
1.4 Global Live Cell Encapsulation Market Size & Forecast
1.5 Global Live Cell Encapsulation Market Size and Forecast by Region
1.5.1 Global Live Cell Encapsulation Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Live Cell Encapsulation Market Size by Region, (2016-2021)
1.5.3 North America Live Cell Encapsulation Market Size and Prospect (2016-2026)
1.5.4 Europe Live Cell Encapsulation Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Live Cell Encapsulation Market Size and Prospect (2016-2026)
1.5.6 South America Live Cell Encapsulation Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Live Cell Encapsulation Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Live Cell Encapsulation Market Drivers
1.6.2 Live Cell Encapsulation Market Restraints
1.6.3 Live Cell Encapsulation Trends Analysis

2 Company Profiles
2.1 Viacyte, Inc.
2.1.1 Viacyte, Inc. Details
2.1.2 Viacyte, Inc. Major Business
2.1.3 Viacyte, Inc. Live Cell Encapsulation Product and Solutions
2.1.4 Viacyte, Inc. Live Cell Encapsulation Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Viacyte, Inc. Recent Developments and Future Plans
2.2 Living Cell Technologies Ltd.
2.2.1 Living Cell Technologies Ltd. Details
2.2.2 Living Cell Technologies Ltd. Major Business
2.2.3 Living Cell Technologies Ltd. Live Cell Encapsulation Product and Solutions
2.2.4 Living Cell Technologies Ltd. Live Cell Encapsulation Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Living Cell Technologies Ltd. Recent Developments and Future Plans
2.3 Sigilon Therapeutics, Inc
2.3.1 Sigilon Therapeutics, Inc Details
2.3.2 Sigilon Therapeutics, Inc Major Business
2.3.3 Sigilon Therapeutics, Inc Live Cell Encapsulation Product and Solutions
2.3.4 Sigilon Therapeutics, Inc Live Cell Encapsulation Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Sigilon Therapeutics, Inc Recent Developments and Future Plans
2.4 Sernova Corporation
2.4.1 Sernova Corporation Details
2.4.2 Sernova Corporation Major Business
2.4.3 Sernova Corporation Live Cell Encapsulation Product and Solutions
2.4.4 Sernova Corporation Live Cell Encapsulation Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Sernova Corporation Recent Developments and Future Plans
2.5 PharmaCyte Biotech Inc
2.5.1 PharmaCyte Biotech Inc Details
2.5.2 PharmaCyte Biotech Inc Major Business
2.5.3 PharmaCyte Biotech Inc Live Cell Encapsulation Product and Solutions
2.5.4 PharmaCyte Biotech Inc Live Cell Encapsulation Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 PharmaCyte Biotech Inc Recent Developments and Future Plans
2.6 Gloriana Therapeutics
2.6.1 Gloriana Therapeutics Details
2.6.2 Gloriana Therapeutics Major Business
2.6.3 Gloriana Therapeutics Live Cell Encapsulation Product and Solutions
2.6.4 Gloriana Therapeutics Live Cell Encapsulation Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Gloriana Therapeutics Recent Developments and Future Plans
2.7 Kadimastem
2.7.1 Kadimastem Details
2.7.2 Kadimastem Major Business
2.7.3 Kadimastem Live Cell Encapsulation Product and Solutions
2.7.4 Kadimastem Live Cell Encapsulation Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 Kadimastem Recent Developments and Future Plans
2.8 Beta-O2 Technologies, Inc.
2.8.1 Beta-O2 Technologies, Inc. Details
2.8.2 Beta-O2 Technologies, Inc. Major Business
2.8.3 Beta-O2 Technologies, Inc. Live Cell Encapsulation Product and Solutions
2.8.4 Beta-O2 Technologies, Inc. Live Cell Encapsulation Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 Beta-O2 Technologies, Inc. Recent Developments and Future Plans
2.9 Altucell, Inc.
2.9.1 Altucell, Inc. Details
2.9.2 Altucell, Inc. Major Business
2.9.3 Altucell, Inc. Live Cell Encapsulation Product and Solutions
2.9.4 Altucell, Inc. Live Cell Encapsulation Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 Altucell, Inc. Recent Developments and Future Plans
2.10 Diatranz Otsuka Ltd
2.10.1 Diatranz Otsuka Ltd Details
2.10.2 Diatranz Otsuka Ltd Major Business
2.10.3 Diatranz Otsuka Ltd Live Cell Encapsulation Product and Solutions
2.10.4 Diatranz Otsuka Ltd Live Cell Encapsulation Revenue, Gross Margin and Market Share (2019-2021)
2.10.5 Diatranz Otsuka Ltd Recent Developments and Future Plans

3 Market Competition, by Players
3.1 Global Live Cell Encapsulation Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Live Cell Encapsulation Players Market Share
3.2.2 Top 10 Live Cell Encapsulation Players Market Share
3.2.3 Market Competition Trend
3.3 Live Cell Encapsulation Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans

4 Market Size Segment by Type
4.1 Global Live Cell Encapsulation Revenue and Market Share by Type (2016-2021)
4.2 Global Live Cell Encapsulation Market Forecast by Type (2021-2026)

5 Market Size Segment by Application
5.1 Global Live Cell Encapsulation Revenue Market Share by Application (2016-2021)
5.2 Live Cell Encapsulation Market Forecast by Application (2021-2026)

6 North America by Country, by Type, and by Application
6.1 North America Live Cell Encapsulation Revenue by Type (2016-2026)
6.2 North America Live Cell Encapsulation Revenue by Application (2016-2026)
6.3 North America Live Cell Encapsulation Market Size by Country
6.3.1 North America Live Cell Encapsulation Revenue by Country (2016-2026)
6.3.2 United States Live Cell Encapsulation Market Size and Forecast (2016-2026)
6.3.3 Canada Live Cell Encapsulation Market Size and Forecast (2016-2026)
6.3.4 Mexico Live Cell Encapsulation Market Size and Forecast (2016-2026)

7 Europe by Country, by Type, and by Application
7.1 Europe Live Cell Encapsulation Revenue by Type (2016-2026)
7.2 Europe Live Cell Encapsulation Revenue by Application (2016-2026)
7.3 Europe Live Cell Encapsulation Market Size by Country
7.3.1 Europe Live Cell Encapsulation Revenue by Country (2016-2026)
7.3.2 Germany Live Cell Encapsulation Market Size and Forecast (2016-2026)
7.3.3 France Live Cell Encapsulation Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Live Cell Encapsulation Market Size and Forecast (2016-2026)
7.3.5 Russia Live Cell Encapsulation Market Size and Forecast (2016-2026)
7.3.6 Italy Live Cell Encapsulation Market Size and Forecast (2016-2026)

8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Live Cell Encapsulation Revenue by Type (2016-2026)
8.2 Asia-Pacific Live Cell Encapsulation Revenue by Application (2016-2026)
8.3 Asia-Pacific Live Cell Encapsulation Market Size by Region
8.3.1 Asia-Pacific Live Cell Encapsulation Revenue by Region (2016-2026)
8.3.2 China Live Cell Encapsulation Market Size and Forecast (2016-2026)
8.3.3 Japan Live Cell Encapsulation Market Size and Forecast (2016-2026)
8.3.4 South Korea Live Cell Encapsulation Market Size and Forecast (2016-2026)
8.3.5 India Live Cell Encapsulation Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Live Cell Encapsulation Market Size and Forecast (2016-2026)
8.3.7 Australia Live Cell Encapsulation Market Size and Forecast (2016-2026)

9 South America by Country, by Type, and by Application
9.1 South America Live Cell Encapsulation Revenue by Type (2016-2026)
9.2 South America Live Cell Encapsulation Revenue by Application (2016-2026)
9.3 South America Live Cell Encapsulation Market Size by Country
9.3.1 South America Live Cell Encapsulation Revenue by Country (2016-2026)
9.3.2 Brazil Live Cell Encapsulation Market Size and Forecast (2016-2026)
9.3.3 Argentina Live Cell Encapsulation Market Size and Forecast (2016-2026)

10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Live Cell Encapsulation Revenue by Type (2016-2026)
10.2 Middle East & Africa Live Cell Encapsulation Revenue by Application (2016-2026)
10.3 Middle East & Africa Live Cell Encapsulation Market Size by Country
10.3.1 Middle East & Africa Live Cell Encapsulation Revenue by Country (2016-2026)
10.3.2 Turkey Live Cell Encapsulation Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Live Cell Encapsulation Market Size and Forecast (2016-2026)
10.3.4 UAE Live Cell Encapsulation Market Size and Forecast (2016-2026)

11 Research Findings and Conclusion

12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
btl

Table of Figures

List of Tables
Table 1. Global Live Cell Encapsulation Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Live Cell Encapsulation Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Live Cell Encapsulation Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Live Cell Encapsulation Revenue (USD Million) by Region (2016-2021)
Table 5. Global Live Cell Encapsulation Revenue Market Share by Region (2021-2026)
Table 6. Viacyte, Inc. Corporate Information, Head Office, and Major Competitors
Table 7. Viacyte, Inc. Major Business
Table 8. Viacyte, Inc. Live Cell Encapsulation Product and Solutions
Table 9. Viacyte, Inc. Live Cell Encapsulation Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Living Cell Technologies Ltd. Corporate Information, Head Office, and Major Competitors
Table 11. Living Cell Technologies Ltd. Major Business
Table 12. Living Cell Technologies Ltd. Live Cell Encapsulation Product and Solutions
Table 13. Living Cell Technologies Ltd. Live Cell Encapsulation Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Sigilon Therapeutics, Inc Corporate Information, Head Office, and Major Competitors
Table 15. Sigilon Therapeutics, Inc Major Business
Table 16. Sigilon Therapeutics, Inc Live Cell Encapsulation Product and Solutions
Table 17. Sigilon Therapeutics, Inc Live Cell Encapsulation Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Sernova Corporation Corporate Information, Head Office, and Major Competitors
Table 19. Sernova Corporation Major Business
Table 20. Sernova Corporation Live Cell Encapsulation Product and Solutions
Table 21. Sernova Corporation Live Cell Encapsulation Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. PharmaCyte Biotech Inc Corporate Information, Head Office, and Major Competitors
Table 23. PharmaCyte Biotech Inc Major Business
Table 24. PharmaCyte Biotech Inc Live Cell Encapsulation Product and Solutions
Table 25. PharmaCyte Biotech Inc Live Cell Encapsulation Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Gloriana Therapeutics Corporate Information, Head Office, and Major Competitors
Table 27. Gloriana Therapeutics Major Business
Table 28. Gloriana Therapeutics Live Cell Encapsulation Product and Solutions
Table 29. Gloriana Therapeutics Live Cell Encapsulation Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. Kadimastem Corporate Information, Head Office, and Major Competitors
Table 31. Kadimastem Major Business
Table 32. Kadimastem Live Cell Encapsulation Product and Solutions
Table 33. Kadimastem Live Cell Encapsulation Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. Beta-O2 Technologies, Inc. Corporate Information, Head Office, and Major Competitors
Table 35. Beta-O2 Technologies, Inc. Major Business
Table 36. Beta-O2 Technologies, Inc. Live Cell Encapsulation Product and Solutions
Table 37. Beta-O2 Technologies, Inc. Live Cell Encapsulation Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. Altucell, Inc. Corporate Information, Head Office, and Major Competitors
Table 39. Altucell, Inc. Major Business
Table 40. Altucell, Inc. Live Cell Encapsulation Product and Solutions
Table 41. Altucell, Inc. Live Cell Encapsulation Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 42. Diatranz Otsuka Ltd Corporate Information, Head Office, and Major Competitors
Table 43. Diatranz Otsuka Ltd Major Business
Table 44. Diatranz Otsuka Ltd Live Cell Encapsulation Product and Solutions
Table 45. Diatranz Otsuka Ltd Live Cell Encapsulation Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 46. Global Live Cell Encapsulation Revenue (USD Million) by Players (2019-2021)
Table 47. Global Live Cell Encapsulation Revenue Share by Players (2019-2021)
Table 48. Breakdown of Live Cell Encapsulation by Company Type (Tier 1, Tier 2 and Tier 3)
Table 49. Live Cell Encapsulation Players Head Office, Products and Services Provided
Table 50. Live Cell Encapsulation Mergers & Acquisitions in the Past Five Years
Table 51. Live Cell Encapsulation New Entrants and Expansion Plans
Table 52. Global Live Cell Encapsulation Revenue (USD Million) by Type (2016-2021)
Table 53. Global Live Cell Encapsulation Revenue Share by Type (2016-2021)
Table 54. Global Live Cell Encapsulation Revenue Forecast by Type (2021-2026)
Table 55. Global Live Cell Encapsulation Revenue by Application (2016-2021)
Table 56. Global Live Cell Encapsulation Revenue Forecast by Application (2021-2026)
Table 57. North America Live Cell Encapsulation Revenue by Type (2016-2021) & (USD Million)
Table 58. North America Live Cell Encapsulation Revenue by Type (2021-2026) & (USD Million)
Table 59. North America Live Cell Encapsulation Revenue by Application (2016-2021) & (USD Million)
Table 60. North America Live Cell Encapsulation Revenue by Application (2021-2026) & (USD Million)
Table 61. North America Live Cell Encapsulation Revenue by Country (2016-2021) & (USD Million)
Table 62. North America Live Cell Encapsulation Revenue by Country (2021-2026) & (USD Million)
Table 63. Europe Live Cell Encapsulation Revenue by Type (2016-2021) & (USD Million)
Table 64. Europe Live Cell Encapsulation Revenue by Type (2021-2026) & (USD Million)
Table 65. Europe Live Cell Encapsulation Revenue by Application (2016-2021) & (USD Million)
Table 66. Europe Live Cell Encapsulation Revenue by Application (2021-2026) & (USD Million)
Table 67. Europe Live Cell Encapsulation Revenue by Country (2016-2021) & (USD Million)
Table 68. Europe Live Cell Encapsulation Revenue by Country (2021-2026) & (USD Million)
Table 69. Asia-Pacific Live Cell Encapsulation Revenue by Type (2016-2021) & (USD Million)
Table 70. Asia-Pacific Live Cell Encapsulation Revenue by Type (2021-2026) & (USD Million)
Table 71. Asia-Pacific Live Cell Encapsulation Revenue by Application (2016-2021) & (USD Million)
Table 72. Asia-Pacific Live Cell Encapsulation Revenue by Application (2021-2026) & (USD Million)
Table 73. Asia-Pacific Live Cell Encapsulation Revenue by Region (2016-2021) & (USD Million)
Table 74. Asia-Pacific Live Cell Encapsulation Revenue by Region (2021-2026) & (USD Million)
Table 75. South America Live Cell Encapsulation Revenue by Type (2016-2021) & (USD Million)
Table 76. South America Live Cell Encapsulation Revenue by Type (2021-2026) & (USD Million)
Table 77. South America Live Cell Encapsulation Revenue by Application (2016-2021) & (USD Million)
Table 78. South America Live Cell Encapsulation Revenue by Application (2021-2026) & (USD Million)
Table 79. South America Live Cell Encapsulation Revenue by Country (2016-2021) & (USD Million)
Table 80. South America Live Cell Encapsulation Revenue by Country (2021-2026) & (USD Million)
Table 81. Middle East & Africa Live Cell Encapsulation Revenue by Type (2016-2021) & (USD Million)
Table 82. Middle East & Africa Live Cell Encapsulation Revenue by Type (2021-2026) & (USD Million)
Table 83. Middle East & Africa Live Cell Encapsulation Revenue by Application (2016-2021) & (USD Million)
Table 84. Middle East & Africa Live Cell Encapsulation Revenue by Application (2021-2026) & (USD Million)
Table 85. Middle East & Africa Live Cell Encapsulation Revenue by Country (2016-2021) & (USD Million)
Table 86. Middle East & Africa Live Cell Encapsulation Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Live Cell Encapsulation Picture
Figure 2. Global Live Cell Encapsulation Revenue Market Share by Type in 2020
Figure 3. Alginate
Figure 4. Chitosan
Figure 5. Cellulose
Figure 6. Others
Figure 7. Live Cell Encapsulation Revenue Market Share by Application in 2020
Figure 8. Diabetes Picture
Figure 9. Cancer Picture
Figure 10. Epilepsy Picture
Figure 11. Parkinson Picture
Figure 12. Others Picture
Figure 13. Global Live Cell Encapsulation Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 14. Global Live Cell Encapsulation Revenue and Forecast (2016-2026) & (USD Million)
Figure 15. Global Live Cell Encapsulation Revenue Market Share by Region (2016-2026)
Figure 16. Global Live Cell Encapsulation Revenue Market Share by Region in 2020
Figure 17. North America Live Cell Encapsulation Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. Europe Live Cell Encapsulation Revenue (USD Million) and Growth Rate (2016-2026)
Figure 19. Asia-Pacific Live Cell Encapsulation Revenue (USD Million) and Growth Rate (2016-2026)
Figure 20. South America Live Cell Encapsulation Revenue (USD Million) and Growth Rate (2016-2026)
Figure 21. Middle East and Africa Live Cell Encapsulation Revenue (USD Million) and Growth Rate (2016-2026)
Figure 22. Live Cell Encapsulation Market Drivers
Figure 23. Live Cell Encapsulation Market Restraints
Figure 24. Live Cell Encapsulation Market Trends
Figure 25. Viacyte, Inc. Recent Developments and Future Plans
Figure 26. Living Cell Technologies Ltd. Recent Developments and Future Plans
Figure 27. Sigilon Therapeutics, Inc Recent Developments and Future Plans
Figure 28. Sernova Corporation Recent Developments and Future Plans
Figure 29. PharmaCyte Biotech Inc Recent Developments and Future Plans
Figure 30. Gloriana Therapeutics Recent Developments and Future Plans
Figure 31. Kadimastem Recent Developments and Future Plans
Figure 32. Beta-O2 Technologies, Inc. Recent Developments and Future Plans
Figure 33. Altucell, Inc. Recent Developments and Future Plans
Figure 34. Diatranz Otsuka Ltd Recent Developments and Future Plans
Figure 35. Global Live Cell Encapsulation Revenue Share by Players in 2020
Figure 36. Live Cell Encapsulation Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 37. Global Top 3 Players Live Cell Encapsulation Revenue Market Share in 2020
Figure 38. Global Top 10 Players Live Cell Encapsulation Revenue Market Share in 2020
Figure 39. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 40. Global Live Cell Encapsulation Revenue Share by Type in 2020
Figure 41. Global Live Cell Encapsulation Market Share Forecast by Type (2021-2026)
Figure 42. Global Live Cell Encapsulation Revenue Share by Application in 2020
Figure 43. Global Live Cell Encapsulation Market Share Forecast by Application (2021-2026)
Figure 44. North America Live Cell Encapsulation Sales Market Share by Type (2016-2026)
Figure 45. North America Live Cell Encapsulation Sales Market Share by Application (2016-2026)
Figure 46. North America Live Cell Encapsulation Revenue Market Share by Country (2016-2026)
Figure 47. United States Live Cell Encapsulation Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. Canada Live Cell Encapsulation Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. Mexico Live Cell Encapsulation Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. Europe Live Cell Encapsulation Sales Market Share by Type (2016-2026)
Figure 51. Europe Live Cell Encapsulation Sales Market Share by Application (2016-2026)
Figure 52. Europe Live Cell Encapsulation Revenue Market Share by Country (2016-2026)
Figure 53. Germany Live Cell Encapsulation Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. France Live Cell Encapsulation Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. United Kingdom Live Cell Encapsulation Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. Russia Live Cell Encapsulation Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. Italy Live Cell Encapsulation Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. Asia-Pacific Live Cell Encapsulation Sales Market Share by Type (2016-2026)
Figure 59. Asia-Pacific Live Cell Encapsulation Sales Market Share by Application (2016-2026)
Figure 60. Asia-Pacific Live Cell Encapsulation Revenue Market Share by Region (2016-2026)
Figure 61. China Live Cell Encapsulation Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. Japan Live Cell Encapsulation Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. South Korea Live Cell Encapsulation Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. India Live Cell Encapsulation Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. Southeast Asia Live Cell Encapsulation Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. Australia Live Cell Encapsulation Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. South America Live Cell Encapsulation Sales Market Share by Type (2016-2026)
Figure 68. South America Live Cell Encapsulation Sales Market Share by Application (2016-2026)
Figure 69. South America Live Cell Encapsulation Revenue Market Share by Country (2016-2026)
Figure 70. Brazil Live Cell Encapsulation Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 71. Argentina Live Cell Encapsulation Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 72. Middle East and Africa Live Cell Encapsulation Sales Market Share by Type (2016-2026)
Figure 73. Middle East and Africa Live Cell Encapsulation Sales Market Share by Application (2016-2026)
Figure 74. Middle East and Africa Live Cell Encapsulation Revenue Market Share by Country (2016-2026)
Figure 75. Turkey Live Cell Encapsulation Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 76. Saudi Arabia Live Cell Encapsulation Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 77. UAE Live Cell Encapsulation Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 78. Methodology
Figure 79. Research Process and Data Source
btl

Research Methodology

Client Requirements

yuan2

Review and analyze client requirements

yuan2

Discussion of all the project requirements and queries

Flexibility Check

yuan2

Project Feasibility Analysis

yuan2

Finalizing tentative research programme

yuan2

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

yuan2

Determination of key drivers, restraints, challenge, and opportunity

yuan2

Identifies market needs and trends

Market Size Estimation & Forecast

yuan2

Estimation of historical data based on secondary and primary data

yuan2

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

yuan2

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

yuan2

Consideration of geography, region-specific product/service demand for region segments

yuan2

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

tuBiao1

Data Source

yuan2

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

yuan2

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

yuan2

Collection of data

yuan2

Cumulating and collating the essential qualitative and quantitative data

yuan2

Generation of report in client requested format by research analysts

yuan2

Reviews by expert analysts

yuan2

Final quality check

yuan2

Clarifying queries

yuan2

Receiving feedback

yuan2

Ensuring satisfaction

  • yuan01
    liuCheng01

    01 Identification of data

    This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.

  • yuan01
    liuCheng01

    02 Evaluation of Market Dynamic

    This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.

  • yuan01
    liuCheng01

    03 Collection of Data

    This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.

  • yuan01
    liuCheng01

    04 Collaboration of Data

    This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.

  • yuan01
    liuCheng01

    05 Verification and Analysis

    This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

btl

Companies Mentioned

Viacyte, Inc.
Living Cell Technologies Ltd.
Sigilon Therapeutics, Inc
Sernova Corporation
PharmaCyte Biotech Inc
Gloriana Therapeutics
Kadimastem
Beta-O2 Technologies, Inc.
Altucell, Inc.
Diatranz Otsuka Ltd
btl

Related Reports

Global Live Cell Encapsulation Market 2023 by Company, Regions, Type and Application, Forecast to 2029 xian22

Global Live Cell Encapsulation Market 2023 by Company, Regions, Type and Application, Forecast to 2029

date 18 Mar 2023

date Pharma & Healthcare

Live cell encapsulation has long been proposed as a solution in modern medicine to many therapeutic problems. Cell encapsulation technology is used for the immobilization of cells within biocompatible and semipermeable membranes. The encapsulation of cells, instead of therapeutic products, is used to allow the delivery of molecules of interest for a longer time period as cells release these molecules of interest continuously. Furthermore, cells can be engineered for expressing the protein of interest in vivo without modifying the host’s genome. Cell encapsulation presents a significant advantage compared to protein encapsulation, as cell encapsulation allows a sustained and controlled delivery therapeutic molecules at a constant rate, thereby resulting in greater physiological concentrations.

shop_t

Purchase Options

jiaGou

Add To Cart

jiaGou

Buy Now

masterCard
visa
jcb
americanExpress
shop_b
Global Live Cell Encapsulation Market 2021 by Company, Regions, Type and Application, Forecast to 2026

Global Live Cell Encapsulation Market 2021 by Company, Regions, Type and Application, Forecast to 2026

Page: 91

Published Date: 09 Jul 2021

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description

arrow-d3
btl

Description

The Live Cell Encapsulation market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Live Cell Encapsulation size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global Live Cell Encapsulation market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation
Live Cell Encapsulation market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
Alginate
Chitosan
Cellulose
Others

Market segment by Application, can be divided into
Diabetes
Cancer
Epilepsy
Parkinson
Others

Market segment by players, this report covers
Viacyte, Inc.
Living Cell Technologies Ltd.
Sigilon Therapeutics, Inc
Sernova Corporation
PharmaCyte Biotech Inc
Gloriana Therapeutics
Kadimastem
Beta-O2 Technologies, Inc.
Altucell, Inc.
Diatranz Otsuka Ltd

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Live Cell Encapsulation product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Live Cell Encapsulation, with revenue, gross margin and global market share of Live Cell Encapsulation from 2019 to 2021.
Chapter 3, the Live Cell Encapsulation competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by type and application, with revenue and growth rate by type, application, from 2016 to 2026.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2016 to 2021.and Live Cell Encapsulation market forecast, by regions, type and application, with revenue, from 2021 to 2026.
Chapter 11 and 12, to describe Live Cell Encapsulation research findings and conclusion, appendix and data source.
btl

Table of Contents

1 Market Overview
1.1 Product Overview and Scope of Live Cell Encapsulation
1.2 Classification of Live Cell Encapsulation by Type
1.2.1 Overview: Global Live Cell Encapsulation Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Live Cell Encapsulation Revenue Market Share by Type in 2020
1.2.3 Alginate
1.2.4 Chitosan
1.2.5 Cellulose
1.2.6 Others
1.3 Global Live Cell Encapsulation Market by Application
1.3.1 Overview: Global Live Cell Encapsulation Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Diabetes
1.3.3 Cancer
1.3.4 Epilepsy
1.3.5 Parkinson
1.3.6 Others
1.4 Global Live Cell Encapsulation Market Size & Forecast
1.5 Global Live Cell Encapsulation Market Size and Forecast by Region
1.5.1 Global Live Cell Encapsulation Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Live Cell Encapsulation Market Size by Region, (2016-2021)
1.5.3 North America Live Cell Encapsulation Market Size and Prospect (2016-2026)
1.5.4 Europe Live Cell Encapsulation Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Live Cell Encapsulation Market Size and Prospect (2016-2026)
1.5.6 South America Live Cell Encapsulation Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Live Cell Encapsulation Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Live Cell Encapsulation Market Drivers
1.6.2 Live Cell Encapsulation Market Restraints
1.6.3 Live Cell Encapsulation Trends Analysis

2 Company Profiles
2.1 Viacyte, Inc.
2.1.1 Viacyte, Inc. Details
2.1.2 Viacyte, Inc. Major Business
2.1.3 Viacyte, Inc. Live Cell Encapsulation Product and Solutions
2.1.4 Viacyte, Inc. Live Cell Encapsulation Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Viacyte, Inc. Recent Developments and Future Plans
2.2 Living Cell Technologies Ltd.
2.2.1 Living Cell Technologies Ltd. Details
2.2.2 Living Cell Technologies Ltd. Major Business
2.2.3 Living Cell Technologies Ltd. Live Cell Encapsulation Product and Solutions
2.2.4 Living Cell Technologies Ltd. Live Cell Encapsulation Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Living Cell Technologies Ltd. Recent Developments and Future Plans
2.3 Sigilon Therapeutics, Inc
2.3.1 Sigilon Therapeutics, Inc Details
2.3.2 Sigilon Therapeutics, Inc Major Business
2.3.3 Sigilon Therapeutics, Inc Live Cell Encapsulation Product and Solutions
2.3.4 Sigilon Therapeutics, Inc Live Cell Encapsulation Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Sigilon Therapeutics, Inc Recent Developments and Future Plans
2.4 Sernova Corporation
2.4.1 Sernova Corporation Details
2.4.2 Sernova Corporation Major Business
2.4.3 Sernova Corporation Live Cell Encapsulation Product and Solutions
2.4.4 Sernova Corporation Live Cell Encapsulation Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Sernova Corporation Recent Developments and Future Plans
2.5 PharmaCyte Biotech Inc
2.5.1 PharmaCyte Biotech Inc Details
2.5.2 PharmaCyte Biotech Inc Major Business
2.5.3 PharmaCyte Biotech Inc Live Cell Encapsulation Product and Solutions
2.5.4 PharmaCyte Biotech Inc Live Cell Encapsulation Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 PharmaCyte Biotech Inc Recent Developments and Future Plans
2.6 Gloriana Therapeutics
2.6.1 Gloriana Therapeutics Details
2.6.2 Gloriana Therapeutics Major Business
2.6.3 Gloriana Therapeutics Live Cell Encapsulation Product and Solutions
2.6.4 Gloriana Therapeutics Live Cell Encapsulation Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Gloriana Therapeutics Recent Developments and Future Plans
2.7 Kadimastem
2.7.1 Kadimastem Details
2.7.2 Kadimastem Major Business
2.7.3 Kadimastem Live Cell Encapsulation Product and Solutions
2.7.4 Kadimastem Live Cell Encapsulation Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 Kadimastem Recent Developments and Future Plans
2.8 Beta-O2 Technologies, Inc.
2.8.1 Beta-O2 Technologies, Inc. Details
2.8.2 Beta-O2 Technologies, Inc. Major Business
2.8.3 Beta-O2 Technologies, Inc. Live Cell Encapsulation Product and Solutions
2.8.4 Beta-O2 Technologies, Inc. Live Cell Encapsulation Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 Beta-O2 Technologies, Inc. Recent Developments and Future Plans
2.9 Altucell, Inc.
2.9.1 Altucell, Inc. Details
2.9.2 Altucell, Inc. Major Business
2.9.3 Altucell, Inc. Live Cell Encapsulation Product and Solutions
2.9.4 Altucell, Inc. Live Cell Encapsulation Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 Altucell, Inc. Recent Developments and Future Plans
2.10 Diatranz Otsuka Ltd
2.10.1 Diatranz Otsuka Ltd Details
2.10.2 Diatranz Otsuka Ltd Major Business
2.10.3 Diatranz Otsuka Ltd Live Cell Encapsulation Product and Solutions
2.10.4 Diatranz Otsuka Ltd Live Cell Encapsulation Revenue, Gross Margin and Market Share (2019-2021)
2.10.5 Diatranz Otsuka Ltd Recent Developments and Future Plans

3 Market Competition, by Players
3.1 Global Live Cell Encapsulation Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Live Cell Encapsulation Players Market Share
3.2.2 Top 10 Live Cell Encapsulation Players Market Share
3.2.3 Market Competition Trend
3.3 Live Cell Encapsulation Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans

4 Market Size Segment by Type
4.1 Global Live Cell Encapsulation Revenue and Market Share by Type (2016-2021)
4.2 Global Live Cell Encapsulation Market Forecast by Type (2021-2026)

5 Market Size Segment by Application
5.1 Global Live Cell Encapsulation Revenue Market Share by Application (2016-2021)
5.2 Live Cell Encapsulation Market Forecast by Application (2021-2026)

6 North America by Country, by Type, and by Application
6.1 North America Live Cell Encapsulation Revenue by Type (2016-2026)
6.2 North America Live Cell Encapsulation Revenue by Application (2016-2026)
6.3 North America Live Cell Encapsulation Market Size by Country
6.3.1 North America Live Cell Encapsulation Revenue by Country (2016-2026)
6.3.2 United States Live Cell Encapsulation Market Size and Forecast (2016-2026)
6.3.3 Canada Live Cell Encapsulation Market Size and Forecast (2016-2026)
6.3.4 Mexico Live Cell Encapsulation Market Size and Forecast (2016-2026)

7 Europe by Country, by Type, and by Application
7.1 Europe Live Cell Encapsulation Revenue by Type (2016-2026)
7.2 Europe Live Cell Encapsulation Revenue by Application (2016-2026)
7.3 Europe Live Cell Encapsulation Market Size by Country
7.3.1 Europe Live Cell Encapsulation Revenue by Country (2016-2026)
7.3.2 Germany Live Cell Encapsulation Market Size and Forecast (2016-2026)
7.3.3 France Live Cell Encapsulation Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Live Cell Encapsulation Market Size and Forecast (2016-2026)
7.3.5 Russia Live Cell Encapsulation Market Size and Forecast (2016-2026)
7.3.6 Italy Live Cell Encapsulation Market Size and Forecast (2016-2026)

8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Live Cell Encapsulation Revenue by Type (2016-2026)
8.2 Asia-Pacific Live Cell Encapsulation Revenue by Application (2016-2026)
8.3 Asia-Pacific Live Cell Encapsulation Market Size by Region
8.3.1 Asia-Pacific Live Cell Encapsulation Revenue by Region (2016-2026)
8.3.2 China Live Cell Encapsulation Market Size and Forecast (2016-2026)
8.3.3 Japan Live Cell Encapsulation Market Size and Forecast (2016-2026)
8.3.4 South Korea Live Cell Encapsulation Market Size and Forecast (2016-2026)
8.3.5 India Live Cell Encapsulation Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Live Cell Encapsulation Market Size and Forecast (2016-2026)
8.3.7 Australia Live Cell Encapsulation Market Size and Forecast (2016-2026)

9 South America by Country, by Type, and by Application
9.1 South America Live Cell Encapsulation Revenue by Type (2016-2026)
9.2 South America Live Cell Encapsulation Revenue by Application (2016-2026)
9.3 South America Live Cell Encapsulation Market Size by Country
9.3.1 South America Live Cell Encapsulation Revenue by Country (2016-2026)
9.3.2 Brazil Live Cell Encapsulation Market Size and Forecast (2016-2026)
9.3.3 Argentina Live Cell Encapsulation Market Size and Forecast (2016-2026)

10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Live Cell Encapsulation Revenue by Type (2016-2026)
10.2 Middle East & Africa Live Cell Encapsulation Revenue by Application (2016-2026)
10.3 Middle East & Africa Live Cell Encapsulation Market Size by Country
10.3.1 Middle East & Africa Live Cell Encapsulation Revenue by Country (2016-2026)
10.3.2 Turkey Live Cell Encapsulation Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Live Cell Encapsulation Market Size and Forecast (2016-2026)
10.3.4 UAE Live Cell Encapsulation Market Size and Forecast (2016-2026)

11 Research Findings and Conclusion

12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
btl

Table of Figures

List of Tables
Table 1. Global Live Cell Encapsulation Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Live Cell Encapsulation Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Live Cell Encapsulation Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Live Cell Encapsulation Revenue (USD Million) by Region (2016-2021)
Table 5. Global Live Cell Encapsulation Revenue Market Share by Region (2021-2026)
Table 6. Viacyte, Inc. Corporate Information, Head Office, and Major Competitors
Table 7. Viacyte, Inc. Major Business
Table 8. Viacyte, Inc. Live Cell Encapsulation Product and Solutions
Table 9. Viacyte, Inc. Live Cell Encapsulation Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Living Cell Technologies Ltd. Corporate Information, Head Office, and Major Competitors
Table 11. Living Cell Technologies Ltd. Major Business
Table 12. Living Cell Technologies Ltd. Live Cell Encapsulation Product and Solutions
Table 13. Living Cell Technologies Ltd. Live Cell Encapsulation Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Sigilon Therapeutics, Inc Corporate Information, Head Office, and Major Competitors
Table 15. Sigilon Therapeutics, Inc Major Business
Table 16. Sigilon Therapeutics, Inc Live Cell Encapsulation Product and Solutions
Table 17. Sigilon Therapeutics, Inc Live Cell Encapsulation Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Sernova Corporation Corporate Information, Head Office, and Major Competitors
Table 19. Sernova Corporation Major Business
Table 20. Sernova Corporation Live Cell Encapsulation Product and Solutions
Table 21. Sernova Corporation Live Cell Encapsulation Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. PharmaCyte Biotech Inc Corporate Information, Head Office, and Major Competitors
Table 23. PharmaCyte Biotech Inc Major Business
Table 24. PharmaCyte Biotech Inc Live Cell Encapsulation Product and Solutions
Table 25. PharmaCyte Biotech Inc Live Cell Encapsulation Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Gloriana Therapeutics Corporate Information, Head Office, and Major Competitors
Table 27. Gloriana Therapeutics Major Business
Table 28. Gloriana Therapeutics Live Cell Encapsulation Product and Solutions
Table 29. Gloriana Therapeutics Live Cell Encapsulation Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. Kadimastem Corporate Information, Head Office, and Major Competitors
Table 31. Kadimastem Major Business
Table 32. Kadimastem Live Cell Encapsulation Product and Solutions
Table 33. Kadimastem Live Cell Encapsulation Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. Beta-O2 Technologies, Inc. Corporate Information, Head Office, and Major Competitors
Table 35. Beta-O2 Technologies, Inc. Major Business
Table 36. Beta-O2 Technologies, Inc. Live Cell Encapsulation Product and Solutions
Table 37. Beta-O2 Technologies, Inc. Live Cell Encapsulation Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. Altucell, Inc. Corporate Information, Head Office, and Major Competitors
Table 39. Altucell, Inc. Major Business
Table 40. Altucell, Inc. Live Cell Encapsulation Product and Solutions
Table 41. Altucell, Inc. Live Cell Encapsulation Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 42. Diatranz Otsuka Ltd Corporate Information, Head Office, and Major Competitors
Table 43. Diatranz Otsuka Ltd Major Business
Table 44. Diatranz Otsuka Ltd Live Cell Encapsulation Product and Solutions
Table 45. Diatranz Otsuka Ltd Live Cell Encapsulation Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 46. Global Live Cell Encapsulation Revenue (USD Million) by Players (2019-2021)
Table 47. Global Live Cell Encapsulation Revenue Share by Players (2019-2021)
Table 48. Breakdown of Live Cell Encapsulation by Company Type (Tier 1, Tier 2 and Tier 3)
Table 49. Live Cell Encapsulation Players Head Office, Products and Services Provided
Table 50. Live Cell Encapsulation Mergers & Acquisitions in the Past Five Years
Table 51. Live Cell Encapsulation New Entrants and Expansion Plans
Table 52. Global Live Cell Encapsulation Revenue (USD Million) by Type (2016-2021)
Table 53. Global Live Cell Encapsulation Revenue Share by Type (2016-2021)
Table 54. Global Live Cell Encapsulation Revenue Forecast by Type (2021-2026)
Table 55. Global Live Cell Encapsulation Revenue by Application (2016-2021)
Table 56. Global Live Cell Encapsulation Revenue Forecast by Application (2021-2026)
Table 57. North America Live Cell Encapsulation Revenue by Type (2016-2021) & (USD Million)
Table 58. North America Live Cell Encapsulation Revenue by Type (2021-2026) & (USD Million)
Table 59. North America Live Cell Encapsulation Revenue by Application (2016-2021) & (USD Million)
Table 60. North America Live Cell Encapsulation Revenue by Application (2021-2026) & (USD Million)
Table 61. North America Live Cell Encapsulation Revenue by Country (2016-2021) & (USD Million)
Table 62. North America Live Cell Encapsulation Revenue by Country (2021-2026) & (USD Million)
Table 63. Europe Live Cell Encapsulation Revenue by Type (2016-2021) & (USD Million)
Table 64. Europe Live Cell Encapsulation Revenue by Type (2021-2026) & (USD Million)
Table 65. Europe Live Cell Encapsulation Revenue by Application (2016-2021) & (USD Million)
Table 66. Europe Live Cell Encapsulation Revenue by Application (2021-2026) & (USD Million)
Table 67. Europe Live Cell Encapsulation Revenue by Country (2016-2021) & (USD Million)
Table 68. Europe Live Cell Encapsulation Revenue by Country (2021-2026) & (USD Million)
Table 69. Asia-Pacific Live Cell Encapsulation Revenue by Type (2016-2021) & (USD Million)
Table 70. Asia-Pacific Live Cell Encapsulation Revenue by Type (2021-2026) & (USD Million)
Table 71. Asia-Pacific Live Cell Encapsulation Revenue by Application (2016-2021) & (USD Million)
Table 72. Asia-Pacific Live Cell Encapsulation Revenue by Application (2021-2026) & (USD Million)
Table 73. Asia-Pacific Live Cell Encapsulation Revenue by Region (2016-2021) & (USD Million)
Table 74. Asia-Pacific Live Cell Encapsulation Revenue by Region (2021-2026) & (USD Million)
Table 75. South America Live Cell Encapsulation Revenue by Type (2016-2021) & (USD Million)
Table 76. South America Live Cell Encapsulation Revenue by Type (2021-2026) & (USD Million)
Table 77. South America Live Cell Encapsulation Revenue by Application (2016-2021) & (USD Million)
Table 78. South America Live Cell Encapsulation Revenue by Application (2021-2026) & (USD Million)
Table 79. South America Live Cell Encapsulation Revenue by Country (2016-2021) & (USD Million)
Table 80. South America Live Cell Encapsulation Revenue by Country (2021-2026) & (USD Million)
Table 81. Middle East & Africa Live Cell Encapsulation Revenue by Type (2016-2021) & (USD Million)
Table 82. Middle East & Africa Live Cell Encapsulation Revenue by Type (2021-2026) & (USD Million)
Table 83. Middle East & Africa Live Cell Encapsulation Revenue by Application (2016-2021) & (USD Million)
Table 84. Middle East & Africa Live Cell Encapsulation Revenue by Application (2021-2026) & (USD Million)
Table 85. Middle East & Africa Live Cell Encapsulation Revenue by Country (2016-2021) & (USD Million)
Table 86. Middle East & Africa Live Cell Encapsulation Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Live Cell Encapsulation Picture
Figure 2. Global Live Cell Encapsulation Revenue Market Share by Type in 2020
Figure 3. Alginate
Figure 4. Chitosan
Figure 5. Cellulose
Figure 6. Others
Figure 7. Live Cell Encapsulation Revenue Market Share by Application in 2020
Figure 8. Diabetes Picture
Figure 9. Cancer Picture
Figure 10. Epilepsy Picture
Figure 11. Parkinson Picture
Figure 12. Others Picture
Figure 13. Global Live Cell Encapsulation Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 14. Global Live Cell Encapsulation Revenue and Forecast (2016-2026) & (USD Million)
Figure 15. Global Live Cell Encapsulation Revenue Market Share by Region (2016-2026)
Figure 16. Global Live Cell Encapsulation Revenue Market Share by Region in 2020
Figure 17. North America Live Cell Encapsulation Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. Europe Live Cell Encapsulation Revenue (USD Million) and Growth Rate (2016-2026)
Figure 19. Asia-Pacific Live Cell Encapsulation Revenue (USD Million) and Growth Rate (2016-2026)
Figure 20. South America Live Cell Encapsulation Revenue (USD Million) and Growth Rate (2016-2026)
Figure 21. Middle East and Africa Live Cell Encapsulation Revenue (USD Million) and Growth Rate (2016-2026)
Figure 22. Live Cell Encapsulation Market Drivers
Figure 23. Live Cell Encapsulation Market Restraints
Figure 24. Live Cell Encapsulation Market Trends
Figure 25. Viacyte, Inc. Recent Developments and Future Plans
Figure 26. Living Cell Technologies Ltd. Recent Developments and Future Plans
Figure 27. Sigilon Therapeutics, Inc Recent Developments and Future Plans
Figure 28. Sernova Corporation Recent Developments and Future Plans
Figure 29. PharmaCyte Biotech Inc Recent Developments and Future Plans
Figure 30. Gloriana Therapeutics Recent Developments and Future Plans
Figure 31. Kadimastem Recent Developments and Future Plans
Figure 32. Beta-O2 Technologies, Inc. Recent Developments and Future Plans
Figure 33. Altucell, Inc. Recent Developments and Future Plans
Figure 34. Diatranz Otsuka Ltd Recent Developments and Future Plans
Figure 35. Global Live Cell Encapsulation Revenue Share by Players in 2020
Figure 36. Live Cell Encapsulation Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 37. Global Top 3 Players Live Cell Encapsulation Revenue Market Share in 2020
Figure 38. Global Top 10 Players Live Cell Encapsulation Revenue Market Share in 2020
Figure 39. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 40. Global Live Cell Encapsulation Revenue Share by Type in 2020
Figure 41. Global Live Cell Encapsulation Market Share Forecast by Type (2021-2026)
Figure 42. Global Live Cell Encapsulation Revenue Share by Application in 2020
Figure 43. Global Live Cell Encapsulation Market Share Forecast by Application (2021-2026)
Figure 44. North America Live Cell Encapsulation Sales Market Share by Type (2016-2026)
Figure 45. North America Live Cell Encapsulation Sales Market Share by Application (2016-2026)
Figure 46. North America Live Cell Encapsulation Revenue Market Share by Country (2016-2026)
Figure 47. United States Live Cell Encapsulation Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. Canada Live Cell Encapsulation Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. Mexico Live Cell Encapsulation Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. Europe Live Cell Encapsulation Sales Market Share by Type (2016-2026)
Figure 51. Europe Live Cell Encapsulation Sales Market Share by Application (2016-2026)
Figure 52. Europe Live Cell Encapsulation Revenue Market Share by Country (2016-2026)
Figure 53. Germany Live Cell Encapsulation Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. France Live Cell Encapsulation Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. United Kingdom Live Cell Encapsulation Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. Russia Live Cell Encapsulation Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. Italy Live Cell Encapsulation Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. Asia-Pacific Live Cell Encapsulation Sales Market Share by Type (2016-2026)
Figure 59. Asia-Pacific Live Cell Encapsulation Sales Market Share by Application (2016-2026)
Figure 60. Asia-Pacific Live Cell Encapsulation Revenue Market Share by Region (2016-2026)
Figure 61. China Live Cell Encapsulation Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. Japan Live Cell Encapsulation Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. South Korea Live Cell Encapsulation Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. India Live Cell Encapsulation Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. Southeast Asia Live Cell Encapsulation Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. Australia Live Cell Encapsulation Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. South America Live Cell Encapsulation Sales Market Share by Type (2016-2026)
Figure 68. South America Live Cell Encapsulation Sales Market Share by Application (2016-2026)
Figure 69. South America Live Cell Encapsulation Revenue Market Share by Country (2016-2026)
Figure 70. Brazil Live Cell Encapsulation Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 71. Argentina Live Cell Encapsulation Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 72. Middle East and Africa Live Cell Encapsulation Sales Market Share by Type (2016-2026)
Figure 73. Middle East and Africa Live Cell Encapsulation Sales Market Share by Application (2016-2026)
Figure 74. Middle East and Africa Live Cell Encapsulation Revenue Market Share by Country (2016-2026)
Figure 75. Turkey Live Cell Encapsulation Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 76. Saudi Arabia Live Cell Encapsulation Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 77. UAE Live Cell Encapsulation Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 78. Methodology
Figure 79. Research Process and Data Source
btl

Research Methodology

Client Requirements

yuan2

Review and analyze client requirements

yuan2

Discussion of all the project requirements and queries

Flexibility Check

yuan2

Project Feasibility Analysis

yuan2

Finalizing tentative research programme

yuan2

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

yuan2

Determination of key drivers, restraints, challenge, and opportunity

yuan2

Identifies market needs and trends

Market Size Estimation & Forecast

yuan2

Estimation of historical data based on secondary and primary data

yuan2

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

yuan2

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

yuan2

Consideration of geography, region-specific product/service demand for region segments

yuan2

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

tuBiao1

Data Source

yuan2

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

yuan2

Discussion of all the project requirements and queries

Validation and triangulation of secondary and primary source.

yuan2

Collection of data

yuan2

Cumulating and collating the essential qualitative and quantitative data

yuan2

Generation of report in client requested format by research analysts

yuan2

Reviews by expert analysts

yuan2

Final quality check

yuan2

Clarifying queries

yuan2

Receiving feedback

yuan2

Ensuring satisfaction

  • yuan01
    liuCheng01

    01 Identification of data

    This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.

  • yuan01
    liuCheng01

    02 Evaluation of Market Dynamic

    This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.

  • yuan01
    liuCheng01

    03 Collection of Data

    This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.

  • yuan01
    liuCheng01

    04 Collaboration of Data

    This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.

  • yuan01
    liuCheng01

    05 Verification and Analysis

    This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

btl

Companies Mentioned

Viacyte, Inc.
Living Cell Technologies Ltd.
Sigilon Therapeutics, Inc
Sernova Corporation
PharmaCyte Biotech Inc
Gloriana Therapeutics
Kadimastem
Beta-O2 Technologies, Inc.
Altucell, Inc.
Diatranz Otsuka Ltd
btl

Related Reports

Global Live Cell Encapsulation Market 2023 by Company, Regions, Type and Application, Forecast to 2029 xian22
q3

Global Live Cell Encapsulation Market 2023 by Company, Regions, Type and Application, Forecast to 2029

industry 18 Mar 2023

industry Pharma & Healthcare

Live cell encapsulation has long been proposed as a solution in modern medicine to many therapeutic problems. Cell encapsulation technology is used for the immobilization of cells within biocompatible and semipermeable membranes. The encapsulation of cells, instead of therapeutic products, is used to allow the delivery of molecules of interest for a longer time period as cells release these molecules of interest continuously. Furthermore, cells can be engineered for expressing the protein of interest in vivo without modifying the host’s genome. Cell encapsulation presents a significant advantage compared to protein encapsulation, as cell encapsulation allows a sustained and controlled delivery therapeutic molecules at a constant rate, thereby resulting in greater physiological concentrations.

jiaGou

Add To Cart

gouMai

Buy Now